#44 Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis.

Rallis E, Papatheodorou G, Bimpakis E, Butanska D, Menounos P, Papadakis P.
J Eur Acad Dermatol Venereol. 2008;22:523-5.